D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
PUT
Sinclair Inc
SBGI
$1.03B
| $2.01M | ﹤0.01% |
+60,200
| New | +$2.24M |
|
2427
CALL
Medifast
MED
$108M
| $2M | ﹤0.01% |
18,300
+10,000
| +120% | +$968K |
|
2428
PUT
Raymond James Financial
RJF
$33.8B
| $2M | ﹤0.01% |
+33,600
| New | +$1.94M |
|
2429
Chemed
CHE
$7.1B
| $2M | ﹤0.01% |
4,553
-1,462
| -24% | -$615K |
|
2430
PUT
Helmerich & Payne
HP
$3.36B
| $2M | ﹤0.01% |
44,000
-98,700
| -69% | -$3.96M |
|
2431
CRA International
CRAI
$1.24B
| $2M | ﹤0.01% |
36,653
+17,141
| +88% | +$833K |
|
2432
PUT
Sturm, Ruger & Co
RGR
$602M
| $1.99M | ﹤0.01% |
42,400
-3,400
| -7% | -$154K |
|
2433
CALL
Crocs
CROX
$6.62B
| $1.99M | ﹤0.01% |
+47,500
| New | +$1.66M |
|
2434
Carriage Services
CSV
$643M
| $1.99M | ﹤0.01% |
77,556
+22,172
| +40% | +$538K |
|
2435
PUT
Nutanix
NTNX
$16.1B
| $1.99M | ﹤0.01% |
63,500
| – | – |
|
2436
CALL
Zoetis
ZTS
$32.7B
| $1.99M | ﹤0.01% |
15,000
| – | – |
|
2437
New Mountain Finance
NMFC
$661M
| $1.98M | ﹤0.01% |
144,194
+53,010
| +58% | +$718K |
|
|
SAVE
2438
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.98M | ﹤0.01% |
49,100
+10,000
| +26% | +$380K |
|
2439
CALL
Parker-Hannifin
PH
$120B
| $1.98M | ﹤0.01% |
9,600
| – | – |
|
2440
PUT
Ovintiv
OVV
$16.8B
| $1.97M | ﹤0.01% |
84,000
-24,000
| -22% | -$514K |
|
|
TIF
2441
DELISTED
Tiffany & Co.
TIF
| $1.97M | ﹤0.01% |
14,735
+11,465
| +351% | +$1.36M |
|
|
JOYY
2442
JOYY Inc
JOYY
$3.74B
| $1.97M | ﹤0.01% |
37,239
+6,791
| +22% | +$400K |
|
|
ZVO
2443
DELISTED
Zovio Inc. Common Stock
ZVO
| $1.97M | ﹤0.01% |
954,523
-228,826
| -19% | -$457K |
|
2444
CALL
Devon Energy
DVN
$51B
| $1.96M | ﹤0.01% |
75,600
+7,800
| +12% | +$176K |
|
2445
CALL
PBF Energy
PBF
$7.55B
| $1.96M | ﹤0.01% |
62,500
| – | – |
|
2446
Hope Bancorp
HOPE
$1.8B
| $1.96M | ﹤0.01% |
131,688
+47,427
| +56% | +$688K |
|
|
SJR
2447
DELISTED
Shaw Communications Inc.
SJR
| $1.95M | ﹤0.01% |
96,292
-131,035
| -58% | -$2.64M |
|
2448
Phibro Animal Health
PAHC
$1.49B
| $1.95M | ﹤0.01% |
78,628
+50,339
| +178% | +$1.17M |
|
|
SRNE
2449
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.95M | ﹤0.01% |
576,145
+503,174
| +690% | +$1.2M |
|
2450
PLDT
PHI
$4.32B
| $1.94M | ﹤0.01% |
97,113
+68,753
| +242% | +$1.44M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.